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NALP3 Forms an IL-1-Processing
Inflammasome with Increased Activity
in Muckle-Wells Autoinflammatory Disorder
containing protein called ASC binds and activates pro-
caspase-1 (Martinon et al., 2002; Srinivasula et al., 2002;
Wang et al., 2002). ASC contains a C-terminal CARD
motif as well as an N-terminal CARD-like Pyrin domain
(Bertin and DiStefano, 2000; Martinon et al., 2001; Masu-
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Chemin des Boveresses 155 moto et al., 1999; Pawlowski et al., 2001), which associ-
ates with the Pyrin domain of NALPs (Martinon et al.,CH-1066 Epalinges
Switzerland 2001). NALPs are recently identified members of the
NBS/NACHT family (Tschopp et al., 2003) (Figure 1A),2 Unit of Molecular Medicine
Queen Mary’s School of Medicine and Dentistry characterized by an N-terminal Pyrin domain and
C-terminal leucine-rich repeats (LRR). NALP1 is uniqueWhitechapel, London E1 1BG
3 Centre for Amyloidosis and Acute Phase Proteins among the NALP family members, as it contains a
C-terminal extension composed of two distinct do-Department of Medicine
Royal Free Hospital mains, a FIIND domain followed by a CARD domain,
which interacts with and activates caspase-5 (FigureLondon NW3 2PF
United Kingdom 1A) (Tschopp et al., 2003). Thus, a model was proposed
in which both caspase-1 and caspase-5 are activated
upon assembly with NALP1 and ASC to form the inflam-
masome responsible for proIL-1 processing (TschoppSummary
et al., 2003).
Such a model, however, cannot explain how otherMutations within the NALP3/cryopyrin/CIAS1 gene are
responsible for three autoinflammatory disorders: members of the NALP family (NALP2–14, short NALPs;
Figure 1A), which lack the capacity to recruit caspase-5Muckle-Wells syndrome, familial cold autoinflamma-
tory syndrome, and CINCA. The NALP3 protein is ho- due to the absence of the C-terminal CARD domain,
could efficiently process proIL-1. The human genomemologous to NALP1, which is a component of the in-
flammasome, a molecular platform that activates the contains a gene, described as Cardinal/TUCAN/CARD8
(Bouchier-Hayes et al., 2001; Pathan et al., 2001; Raz-proinflammatory caspases-1 and -5. NALP3 (and other
members of the NALP family) lacks the C-terminal, mara et al., 2002), that encodes a protein whose struc-
tural organization is similar to the C terminus of NALP1CARD-containing sequence of NALP1, and its role in
caspase activation is unclear. Here, we report that and corresponds to the sequence missing in NALP pro-
teins 2–14 (Figure 1A). The CARD domain of CardinalNALP2 and NALP3 associate with ASC, the CARD-
containing protein Cardinal, and caspase-1 (but not was reported to interact with caspase-1 (Razmara et al.,
2002) and caspase-9 (Pathan et al., 2001).caspase-5), thereby forming an inflammasome with
high proIL-1-processing activity. Macrophages from
Muckle-Wells patients spontaneously secrete active Results and Discussion
IL-1. Increased inflammasome activity is therefore
likely to be the molecular basis of the symptoms asso- We therefore considered the possibility that Cardinal
ciated with NALP3-dependent autoinflammatory dis- could be the functional homolog of the NALP1 C termi-
orders. nus containing the FIIND and CARD domain and investi-
gated whether it would associate with the short NALPs.
Introduction Indeed, when overexpressed in 293T cells with various
NALP2 and NALP3 constructs, Cardinal was found in
Interleukin-1 (IL-1) functions in the generation of sys- the anti-NALP immunoprecipitates (Figure 1B). Interest-
temic and local responses to infection, injury, and immu- ingly, full-length NALP2 and NALP3 showed little or no
nological challenges and is the primary cause of chronic apparent affinity for Cardinal. Removal of either the
and acute inflammation (Dinarello, 1998). IL-1 is pro- C-terminal LRR, the N-terminal Pyrin, or both domains
duced as an inactive cytoplasmic precursor (proIL-1, was required in order to detect optimal association with
p35) that has to be cleaved by caspase-1 (at Asp116) Cardinal. No interaction of Cardinal was detectable with
to generate the mature active form (p17). Caspase-1, the Pyrin domain of NALP2 and NALP3, indicating that
like the two other proinflammatory caspases, caspase-4 (1) Cardinal interaction was mediated through the
and caspase-5, possesses an N-terminal CARD protein- NACHT domain of NALPs and (2) that the interaction
protein interaction domain (Thornberry and Lazebnik, was internally inhibited by the LRR and the Pyrin do-
1998). mains. This domain-based mechanism of autoinhibition
Although the molecular mechanisms responsible for is also functional in NALP1 (data not shown) and is
the activation of proinflammatory caspases remain similar to the mechanism found in the structurally related
poorly defined, recent evidence indicates that a CARD- Ipaf protein (Poyet et al., 2001). In agreement with previ-
ous work (Pathan et al., 2001), Cardinal was found to
interact with itself. We further mapped the interaction*Correspondence: jurg.tschopp@ib.unil.ch
4 These authors contributed equally to this work. site of the NALPs on Cardinal and found the FIIND do-
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Figure 1. NALP3 Interacts with Cardinal
(A) Domain structure of NALP1 (long NALP), NALP2 to NALP14 (short NALPs), and Cardinal. Note that the number of LRR repeats in NALP2–14
varies from 0 to 14. Caspase recruitment domain, CARD; Pyrin domain, PYD; leucine-rich repeats, LRR; NALP-associated domain, NAD;
domain present in NAIP, CIITA, HET-E, and TP1, NACHT; domain with function to find, FIIND.
(B) NALP2 and NALP3 interact with Cardinal. VSV-tagged Cardinal was coexpressed in 293T cells with the indicated Flag-tagged expression
constructs containing the Pyrin (P), NACHT/NAD (N), and LRR (L) domains of NALP2 and NALP3, respectively, or with Flag-tagged Cardinal
or IRAK4 as control. Twenty-four hours after transfection, anti-Flag immunoprecipitates (IP) were prepared and analyzed for the presence of
Cardinal. Expression of VSV-Cardinal and of the various Flag-tagged proteins was assayed in cell extracts (Cell xt).
(C) As (B), but only the FIIND domain of Cardinal was expressed.
main to be sufficient for this association to occur (Figure in cells that are stressed due to protein overexpression
or treatment with agents that induce cell death (Masu-1C and data not shown).
The Pyrin domain of NALP1 and ASC interact with moto et al., 1999).
While in the NALP1-containing inflammasome, ASCeach other (Manji et al., 2002; Martinon et al., 2001), and
likewise, we found that the Pyrin domain of both NALP2 is used to recruit caspase-1, the C-terminal CARD of
NALP1 recruits, and activates caspase-5. We thereforeand NALP3 interacted with the Pyrin domain of ASC
(Figure 2A). This interaction was also detectable with investigated whether Cardinal preferentially interacts
with caspase-5 and monitored its interaction with vari-the endogenous ASC, when the FLAG-tagged Pyrin do-
main of either NALP2 or NALP3 was expressed in 293T ous CARD-containing caspases. Unlike NALP1, the
CARD of Cardinal-bound caspase-1 but not caspase-5cells and the cytoplasmic extracts subsequently mixed
with cell extracts from THP-1 cells (Figure 2B). (nor caspase-4 and -9) and, consequently, overexpres-
sion of Cardinal led to caspase-1 and not to caspase-5Further support for the NALP 2 and 3 interaction with
ASC and Cardinal was obtained when the subcellular processing (Figure 2D; data not shown).
Activation of caspase-1 by NALP1 is dependent onlocalization was analyzed by confocal microscopy (Fig-
ure 2C). Granular cytoplasmic staining was obtained the presence of ASC while for caspase-5, ASC is not
required. To investigate whether NALP3 and/or Car-with antibodies to Cardinal, NALP2, and ASC, which
overlapped when images were merged. We did not ob- dinal-induced caspase-1 activation is dependent on the
presence of ASC, we developed an assay in which theserve the speckles previously described for overex-
pressed ASC (Masumoto et al., 2001; Stehlik et al., 2003), inflammasome is reconstituted in 293T cells. 293T cells
do not express any components of the inflammasome.indicating that these prominent structures are only seen
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Figure 2. NALP2 and NALP3 Activate Caspase-1 Indirectly via ASC, while Cardinal Binds Directly to Caspase-1
(A) Flag-tagged NALP2 and NALP3 constructs were immunoprecipitated from transfected 293T cells and the associated VSV-tagged ASC
detected in Western blots. P, Pyrin domain; N, NACHT and NAD domains; L, LRR.
(B) Flag-tagged NALP2 and NALP3 proteins were expressed in 293T cells. Cell extracts were subsequently mixed with cell extracts from
THP-1 monocytic cells and the interaction of Flag-tagged NALP2, NALP3, and ASC with endogenous ASC of THP-1 cells assayed in anti-
Flag immunoprecipitates. Note that ASC also interacts with itself.
(C) The subcellular distribution of NALP2, Cardinal, and ASC was analyzed in THP-1 cells stably transfected with VSV-NALP2 by confocal
microscopy. Right panel, antibody specificity control: Western blot of cell extracts of 293T cells transfected () or not () with Cardinal using
the polyclonal anti-Cardinal antibody.
(D) Various Flag-tagged CARD-containing caspases were expressed in 293T cells together with the CARD of Cardinal and their interaction
assayed in anti-Flag immunoprecipitates. Activation of caspase-1 is evident in immunoblots from cell extracts by the appearance of the
processed enzyme and its capacity to process proIL-1 (see Figure 2E). Caspase-2, another CARD-containing human caspase, did not interact
with Cardinal (data not shown).
(E) Activation of Caspase-1 by NALP3 but not by Cardinal is dependent on ASC. 293T cells were transfected with low amounts of caspase-1
and proIL-1 (100 ng of each plasmid) in each case. The left panel shows that transfection of ASC, NALP1, NALP2, and NALP3 does not
result in the processing of proIL-1, while expression of Cardinal or Ipaf induces weak activation. However, in the presence of low amounts
of ASC, the NALPs become strong activators of proIL-1 as evidenced by the appearance of the active cleaved form of IL-1 (p17, the -D116
antibody used specifically recognizes the processed form). Note that the expressed NALP1 is not Flag-tagged and therefore not detectable
with -Flag antibodies.
As shown in Figure 2C, overexpression of neither NALP1 processing of IL-1. Minute amounts of ASC had to
be transfected to see activation of caspase-1 (higher(N-terminal Pyrin domain, NACHT, and LRR), NALP2,
nor NALP3 alone led to the activation of caspase-1 and concentrations of ASC led to spontaneous activation),
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Figure 3. NALP3 and NALP2, Caspase-1,
ASC, and Cardinal Form Short NALP Inflam-
masomes
(A) Cell extracts of THP-1 cells were incu-
bated at 30C for increasing periods of time
in the presence and absence of z-VAD-fmk,
and association of ASC, caspase-1, and
Cardinal with endogenous NALP3 was moni-
tored in NALP3 immunoprecipitates in the
presence and absence of z-VAD-fmk. Note
that FADD is not incorporated into the com-
plex. Control lane: immunoprecipitate using
an irrelevant control antibody of the same iso-
type. Note that the polyclonal antibody
against caspase-1 used in this experiment
crossreacts with other proteins present in the
cell extracts as indicated (ns). Moreover, cas-
pase-1 appears to stick nonspecifically to
beads, as even in the isotype control some
caspase-1 is already detectable.
(B) As (A), but NALP2 inflammasome assem-
bly was followed in THP-1 cells stably ex-
pressing VSV-NALP2. NALP2 inflammasome
assembly was followed using anti-VSV anti-
bodies. The asterisk points to a putative short
form of ASC. Interestingly, caspase-1 that is
recruited to the inflammasome is modified.
indicating that NALP1, 2, and 3 are strictly dependent creased by coexpression of Cardinal and NALP3 or
NALP2 (data not shown). Taken together, these resultson ASC to exert their role as activators of caspase-1.
Of particular note, NALP3 appeared to be more potent show that an inflammasome with short NALPs can be
assembled that contains ASC, Cardinal, and caspase-1than NALP1, at least in this reconstitution system. In
contrast to the NALPs, Cardinal- and Ipaf- (Poyet et al., and that leads to the potent processing of caspase-1.
Despite the capacity to activate caspase-1, Cardinal2001) induced caspase-1 activation proceeded in the
absence of ASC and, if compared to NALPs, were weak appears to play a minor role in the processing of IL-
1. Preliminary results suggest that it is important foractivators. As expected from this low activity, NALP3-
induced caspase-1 activation was not detectably in- inflammasome association with the cytoskeleton.
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Figure 4. Increased IL-1 Processing in
Macrophages Isolated from a Muckle-Wells
Patient Carrying the R260W Mutation
Purified monocytes from a patient or a nonaf-
fected donor were allowed to adhere over-
night and subsequently stimulated or not with
LPS for 24 hr. Il-1 present in the supernatant
was measured by an ELISA ([A], left panel) or
by Western blotting ([A], right panel) using
an antibody specifically directed against the
active fragment (p17) of proIL-1 (D116). (B)
Kinetics of secretion of TNF and active, pro-
cessed IL-1.
Since the above conclusion is based on overexpres- are themselves dependent on the activation of cas-
pases.sion studies, it was essential to corroborate assembly
with endogenous proteins. We have previously found Considering the potent caspase-1/proIL-1 activity of
the NALP3 inflammasome, the simplest mechanism tothat LPS-mediated assembly of the NALP1 inflamma-
some is difficult to follow as the complex is immediately explain the autoinflammatory disorders associated with
NALP3 mutations would be the spontaneous activationsecreted upon its formation (Martinon et al., 2002). We
therefore took advantage of the same system that has of the inflammasome, ultimately leading to increased
caspase-1 activation and IL-1 release. To test this hy-been successfully used to study assembly of the apo-
ptosome (Li et al., 1997) and the NALP1 inflammasome pothesis, monocytes were isolated from a Muckle-Wells
patient with a NALP3 R260W mutation (Aganna et al.,(Martinon et al., 2002). Cell extracts of THP-1 cells were
incubated at 30C in order to promote the spontaneous 2002) and stimulated with LPS. As shown in Figure 4A,
processed IL-1was detectable in the supernatant evenactivation of the inflammasome. Although inflamma-
some assembly is most conveniently followed by immu- without prior stimulation of the cells. Following a 24
hr LPS stimulation, IL-1 levels further increased. Innoprecipitating ASC (Martinon et al., 2002), we devel-
oped a panel of monoclonal antibodies against NALP3 contrast, IL-1 found in the supernatant of macrophages
from a normal donor was only detectable upon stimula-in order to specifically study the NALP3 inflammasome
and avoid coprecipitation of the NALP1 inflammasome. tion, reaching levels that were only slightly higher than
those found with nonstimulated patient macrophages.Upon activation, assembly of the NALP3 inflammasome
consisting of a complex of NALP3, ASC, caspase-1, and In agreement with a previous report (Aksentijevich et
al., 2002), cytokine levels were generally upregulated inCardinal was detectable after 30–60 min and reached a
maximum after 2 hr (Figure 3A and data not shown). the patient’s monocytes. For example, TNF levels were
significantly higher after LPS stimulation (Figure 4B).These kinetics of assembly were similar to the one pre-
viously found for the NALP1 inflammasome (Martinon TNF release, which is not dependent on caspase pro-
cessing, was found to be a late event as significantet al., 2002). The complex contained ASC, Cardinal, and
caspase-1 but no detectable caspase-5. A small but levels were only detectable 24 hr poststimulation. Unlike
the rapid release of processed IL-1, which was notice-significant portion of caspase-1 was converted into the
processed form, giving rise to the p35 fragment. Cas- able already 2 hr after LPS treatment, TNF secretion
was slow and not detectable after 4 hr. Thus, it is likelypase-1 processing was higher when assembly of the
NALP2 inflammasome was studied in THP-1 cells stably that the increased general cytokine production ob-
served is a consequence of increased IL-1 release.expressing VSV-tagged NALP2 (Figure 3B). Interest-
ingly, the recruitment of Cardinal was abolished in the Since the publication of the initial report demonstra-
ting association of mutations in the NALP3 gene withpresence of the pan-caspase inhibitor z-VAF-fmk, indi-
cating that assembly of the short NALPs inflammasomes Muckle-Wells, familial cold autoinflammatory disorder
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subcloned into the mammalian expression vectors pCR3 in frame(FCAS), or with chronic infantile neurologic cutaneous
with the indicated tags. The caspase-1 expression construct con-and articular (CINCA) autoinflammatory diseases (Hoff-
tains a C-terminal Flag.man et al., 2001), more than 100 patients with those
inflammatory diseases have been diagnosed as carrier Cloning of NALP2, NALP3, and Cardinal
of the mutated NALP3 gene (Hull et al., 2003). The role NALP2 FL was cloned from the EST accession number AK000517,
kindly provided by the NEDO human cDNA sequencing project (Ja-of NALP3 and the biological consequences of such mu-
pan). NALP2 FL (amino acids 1–1062), NALP2 P  N (amino acidstations, however, remained unexplained. This study now
1–589, covering the pyrin and the NACHT domains), NALP2 N (aminoprovides evidence that NALP3 and another short NALP,
acids 89–589, covering the NACHT domain), NALP2 N  L (amino
NALP2, form an inflammasome with Cardinal and ASC acids 89–1062, covering the NACHT and LRR domains), and NALP2
resulting in caspase-1 activation and strong processing P (amino acids 1–112, covering the pyrin domain) were amplified by
of proIL1. Unlike the NALP1 inflammasome, the NALP3 PCR and subcloned into the mammalian expression vectors pCR3 in
frame with the indicated tags. NALP3s was cloned from the ESTinflammasome does not simultaneously activate cas-
accession number AK027194 provided by the NEDO human cDNApase-5. Whether this difference implies different sub-
sequencing project. NALP3s (amino acids 1–717, covering the pyrin,strate preferences, such as IL-1 versus IL-18, remains
the NACHT domain, and the intermediate domain), NALP3 P  N
to be investigated. (amino acids 1–544, covering the pyrin and NACHT domain), NALP3
To date, 23 distinct mutations have been described N (amino acids 67–544, covering the NACHT domain), and NALP3
P (amino acid 1–93, covering the pyrin domain) were amplified byin the NALP3 gene, and they are all localized within the
PCR and subcloned into the mammalian expression vectors pCR3NACHT domain (McDermott, 2002). The most frequent
in frame with the indicated tags. Cardinal was cloned from the ESTR260W mutation is found in patients with MWS and
(KIAA0955) accession number AB023172 provided by the Kazusa
FCAS. We found that monocytes from these patients DNA Research Institute (Japan). Cardinal FL (amino acids 1–431,
display spontaneous processing and secretion of IL- covering the FIIND and the CARD domain), Cardinal FIIND (amino
acids 1–346), Cardinal CARD (amino acids 320–431), and ASC P1, which is detectable in supernatants even without
(amino acids 1–125, covering the pyrin domain) were amplified bystimulation. This increased activity could be explained
PCR and subcloned into the mammalian expression vectors pCR3 inby enhanced propensity for inflammasome assembly
frame with the indicated tags. The construct VSV-NALP2 FL (amino
as the NACHT domain is known to be responsible for acids 1–1062) was cloned in pMSCV puromycin. Expression con-
oligmerization. Alternatively, the mutations may block structs for caspase-1, -4, and -9 have been described elsewhere
binding of a putative inhibitor of inflammasome as- (Thome et al., 1998). The plasmid encoding caspase-5 was a kind
gift of Christoph Froelich.sembly.
The observation that macrophages from a patient with
Cell LinesMWS secrete IL-1 even in the absence of a stimulus
THP-1 and 293T were cultured in RPMI 1640 and DMEM, respec-
predicts a rational treatment, namely the inhibition of tively, supplemented with 10% fetal bovine serum (FCS), 50 mM
the proinflammatory activity of IL-1. Indeed, the admin- -mercaptoethanol, and penicillin/streptomycin (100g/ml of each).
THP-1 stably expressing VSV-NALP2 were cultured with mediumistration of the IL-1 antagonist IL-1Ra (Arend and
supplemented with 5 g/ml puromycin.Guthridge, 2000) to patients with Muckle-Wells syn-
drome proves to be highly successful. In all patients
Transient Transfection and Immunoprecipitation
treated, the inflammatory symptoms cease within hours Transient transfection of 293T cells was performed as described
after the first injection of IL-Ra (Hawkins et al., 2003, previously (Thome et al., 1998). For coimmunoprecipitation experi-
ments, transfected 293T cells (1  106) were suspended in 200 l2004), further supporting the concept that excessive
of lysis buffer (50 mM Tris [pH 7.8], 150 mM NaCl, 0.1% Nonidetinflammasome activation is the causative mechanism in
P-40, 5 mM EDTA) and lysed by three freeze/thaw cycles. Notethese autoinflammatory diseases.
that overexpression of large amounts of Pyrin domain-containing
proteins was avoided as these proteins have a strong tendency to
Experimental Procedures
aggregate and precipitate in insoluble fractions. The lysates were
incubated with 3 g of anti-Flag agarose (Sigma), 3 g of anti-VSV
Antibodies
bound to protein G, or 3 g of anti-ASC (AL177) bound to protein
Polyclonal antibodies against human Cardinal were generated in G at 4C overnight. The agarose beads were washed five times with
rabbits (Eurogentec, Belgium) by injecting GST-cardinal FIIND lysis buffer, and the precipitated proteins were then fractionated on
(AL228). The polyclonal serum were purified on an HiTrap protein 10% and 12% SDS-PAGE and analyzed by Western blotting. For
G HP column (Amersham). Monoclonal antibodies against NALP3 coimmunoprecipitation with endogenous ASC, transfected 293T ly-
were generated from GST-NALP3-immunized mice. Four mono- sates were mixed with THP-1 lysate and were immunoprecipitated
clonal antibodies were purified (Nalpy3a, Nalpy3b, Nalpy3c, Nal- with AL177 as described before.
py3d). Other antibodies were purchased from the following compa-
nies: cleaved IL-1 D116 (Cell Signaling); anti-Flag antibody (M2, ASC Activity Assay
Sigma); anti-VSV antibody (P5D4, Sigma); mAb anti-ASC and FADD Transient transfection of 293T cells was performed using optimal
(MBL); and polyclonal anti-ASC (AL177, Apotech). Peroxidase-con- amounts of each plasmid. Twenty-four hours later, cells were har-
jugated secondary anti-mouse and anti-rabbit antibodies were from vested and the pellets were sonicated in SDS-PAGE buffer with
Jackson IR and isotype-specific anti-IgG1 from Southern Biotech. DTT. The samples were analyzed by SDS-PAGE 15% and by West-
Secondary antibodies for immunofluorescence and Alexa-conju- ern blotting.
gated mouse and rabbit antibodies were purchased from Molecu-
lar Probes. Confocal Microscopy
THP-1 cells were grown on coverslips coated with polylysine. Slides
Plasmids were fixed with paraformaldehyde 4% for 20 min at room tempera-
Cloning of NALP1 and ASC was described previously (Martinon et ture. Slides were blocked (30 min) and immunostained for 1 hr with
al., 2002). NALP1 Cter (amino acids 1030–1430, covering FIIND and the first antibody, anti-VSV, and AL228 in PBS, 2% normal goat
CARD domains), NALP1 P  N (amino acids 1–665, covering the serum, 0.1% saponin for 1 hr at RT. After washing the cells with PBS,
pyrin and NACHT domains), NALP1 Nter (amino acids 1–1079, cov- the cells were stained with the secondary antibody Alexa mouse 488
ering the pyrin, NACHT, and LRR domains), and NALP1 P (amino and rabbit Cy5, respectively. Cells were analyzed with a Zeiss LSM
510 confocal laser scanning microscope through a 63 objective.acids 1–121, covering the pyrin domain) were amplified by PCR and
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Immunoprecipitation of the Inflammasome Hoffman, H.M., Mueller, J.L., Broide, D.H., Wanderer, A.A., and Ko-
lodner, R.D. (2001). Mutation of a new gene encoding a putativeImmunoprecipitation of endogenous caspase-1/NALP3 or NALP2/
ASC/Cardinal interaction were performed using 5 108 THP-1 cells/ pyrin-like protein causes familial cold autoinflammatory syndrome
and Muckle-Wells syndrome. Nat. Genet. 29, 301–305.time point, as described (Martinon et al., 2002). Cell extracts pre-
pared in buffer W (Martinon et al., 2002) were incubated with 3 g Hull, K.M., Shoham, N., Chae, J.J., Aksentijevich, I., and Kastner,
of the indicated antibodies (anti-VSV, anti-NALP3) conjugated to D.L. (2003). The expanding spectrum of systemic autoinflammatory
protein G at 4C for overnight incubation. The immunoprecipitates disorders and their rheumatic manifestations. Curr. Opin. Rheuma-
were recovered by centrifugation and washed six times with buffer tol. 15, 61–69.
W before SDS-PAGE and Western analysis. Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S.M., Ahmad, M.,
Alnemri, E.S., and Wang, X. (1997). Cytochrome c and dATP-depen-
Determination of IL-1 Secretion dent formation of Apaf-1/caspase-9 complex initiates an apoptotic
Using an Optiprep (axis-shield) 1.074 g/ml density barrier solution protease cascade. Cell 91, 479–489.
as described (Graziani-Bowering et al., 1997), 50 ml of fresh blood
Manji, G.A., Wang, L., Geddes, B.J., Brown, M., Merriam, S., Al-
was fractionated from a patient diagnosed as carrier of the R260W
Garawi, A., Mak, S., Lora, J.M., Briskin, M., Jurman, M., et al. (2002).
mutation (Aganna et al., 2002) by density. The patient had been
PYPAF1, a PYRIN-containing Apaf1-like protein that assembles with
treated with anakinra (IL1ra) and was asymptomatic at the time
ASC and regulates activation of NF-kappa B. J. Biol. Chem. 277,
blood was taken.
11570–11575.
The monocyte-containing fraction was plated on 12 wells plate
Martinon, F., Hofmann, K., and Tschopp, J. (2001). The Pyrin domain:(500,000 cells/well) for 12 hr. The medium was replaced with Opti-
a possible member of the death domain-fold family implicated inmem, and the stimulation was done with LPS (10 g/ml) for various
apoptosis and inflammation. Curr. Biol. 10, R118–R120.time periods. The supernatants and the pellets were prepared as
Martinon, F., Burns, K., and Tschopp, J. (2002). The inflammasome.described (Martinon et al., 2002). The concentration of IL1- and
A molecular platform triggering activation of inflammatory caspasesTNF was determined using a kit purchased from Pharmingen and
and processing of proIL-beta. Mol. Cell 10, 417–426.Boehringer, respectively.
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